WS #15764
UnitedHealth Group and Johnson & Johnson reported third-quarter earnings that significantly exceeded analyst estimates, driven by improved medical cost controls and resilient sales. Both companies raised their full-year 2026 adjusted EPS guidance, signaling confidence in their operational efficiency and pricing power. This sector strength provides a stabilizing anchor for the broader market amidst geopolitical volatility.
Healthcare Earnings & Guidance
UnitedHealth Group and Johnson & Johnson reported third-quarter earnings that significantly exceeded analyst estimates, driven by improved medical cost controls and resilient sales. Both companies raised their full-year 2026 adjusted EPS guidance, signaling confidence in their operational efficiency and pricing power. This sector strength provides a stabilizing anchor for the broader market amidst geopolitical volatility.